Back to top
more

Integer Holdings (ITGR)

(Real Time Quote from BATS)

$102.96 USD

102.96
209,821

-0.11 (-0.11%)

Updated Sep 17, 2025 03:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

COO Stock Declines Despite Strong Core Growth Amid Fertility Woes

by Zacks Equity Research

The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System

by Zacks Equity Research

Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.

Zacks Equity Research

SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System

by Zacks Equity Research

Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.

Zacks Equity Research

Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines

by Zacks Equity Research

WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.

Zacks Equity Research

Reasons to Retain TransMedics Stock in Your Portfolio for Now

by Zacks Equity Research

TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.

Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

by Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

Zacks Equity Research

GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications

by Zacks Equity Research

GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.

Zacks Equity Research

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

by Zacks Equity Research

QDEL continues to witness growth on the back of its strong product portfolio.

Zacks Equity Research

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration

by Zacks Equity Research

Beta Bionics collaborates with Abbott to integrate its iLet system with a dual sensor, aiming to simplify and enhance diabetes care.

Zacks Equity Research

Here's Why MOH Shares Are Attracting Prudent Investors Now

by Zacks Equity Research

Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.

Zacks Equity Research

Smith+Nephew Stock May Gain From Strategic Deal With Standard Health

by Zacks Equity Research

SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth.

Zacks Equity Research

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

by Zacks Equity Research

ECL continues to gain from its robust product portfolio and strong segmental performance.

Zacks Equity Research

Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas

by Zacks Equity Research

EHC unveils plans for a 50-bed rehabilitation hospital in North Las Vegas, bringing improved health outcomes to the region's residents and further solidifying its Nevada footprint.

Zacks Equity Research

GE HealthCare Stock Slips Despite the Launch of bkActiv S Series

by Zacks Equity Research

GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.

Zacks Equity Research

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

by Zacks Equity Research

ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.

Zacks Equity Research

VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma

by Zacks Equity Research

Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.

Zacks Equity Research

GEHC Stock Declines Despite Expansion in Precision Care Capabilities

by Zacks Equity Research

GE HealthCare integrates proprietary algorithms into MIM Encore to advance digital imaging and workflow precision.

Zacks Equity Research

INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach

by Zacks Equity Research

Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance for growth.

Zacks Equity Research

Here's Why ENSG Shares Are Attracting Prudent Investors Now

by Zacks Equity Research

The Ensign Group's 23.8% stock gain, strong earnings outlook and low debt levels are drawing investor attention despite rising costs.

Zacks Equity Research

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

by Zacks Equity Research

OPK's growth hinges on RAYALDEE and key partnerships, but rising competition and reliance on one drug pose risks.

Zacks Equity Research

Here's Why Integer (ITGR) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now

by Zacks Equity Research

XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist.

Zacks Equity Research

ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite

by Zacks Equity Research

ZIMV launches RealGUIDE Software Suite and Implant Concierge in Japan to boost digital dental workflows.

Zacks Equity Research

ITGR or PEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?